Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement
暂无分享,去创建一个
James M. Brown | Tracy T Batchelor | Jayashree Kalpathy-Cramer | Wenya Linda Bi | Ken Chang | Joeky T Senders | Raymond Y Huang | Li Yang | Weihua Liao | James M Brown | Chang Su | Andrew L Beers | Omar Arnaout | Patrick Y Wen | Jerrold L Boxerman | Harrison X Bai | Marco C Pinho | B. Rosen | Jayashree Kalpathy-Cramer | P. Wen | J. Boxerman | T. Batchelor | E. Gerstner | Andrew Beers | Ken Chang | Xuejun Li | W. Bi | H. Bai | M. Pinho | Paul J Zhang | Hao Zhou | Chang Su | W. Liao | Li Yang | V. Kavouridis | J. Senders | Alessandro Boaro | Q. Shen | O. Arnaout | O. Rapalino | Elizabeth R Gerstner | Yinyan Wang | Bruce R Rosen | Xuejun Li | Otto Rapalino | K Ina Ly | Vasileios K Kavouridis | Alessandro Boaro | Qin Shen | Hao Zhou | Bo Xiao | K. I. Ly | Yin-yan Wang | Bo Xiao | J. T. Senders
[1] Susan M. Chang,et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Raymond Y Huang,et al. Residual Convolutional Neural Network for the Determination of IDH Status in Low- and High-Grade Gliomas from MR Imaging , 2017, Clinical Cancer Research.
[3] Eudocia Q Lee,et al. The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab , 2015, Clinical Cancer Research.
[4] A Gregory Sorensen,et al. Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study. , 2013, Neuro-oncology.
[5] Thomas Brox,et al. 3D U-Net: Learning Dense Volumetric Segmentation from Sparse Annotation , 2016, MICCAI.
[6] Bruce R. Rosen,et al. Sequential neural networks for biologically informed glioma segmentation , 2018, Medical Imaging.
[7] Benjamin M. Ellingson,et al. Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials , 2017, Neurotherapeutics.
[8] B. Rosen,et al. Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI , 2018, Scientific Reports.
[9] F Barkhof,et al. Interobserver variability in the radiological assessment of response to chemotherapy in glioma , 2003, Neurology.
[10] Wei Tang,et al. Ensembling neural networks: Many could be better than all , 2002, Artif. Intell..
[11] Raymond Y Huang,et al. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas , 2017, Neuro-oncology.
[12] Christopher Joseph Pal,et al. Brain tumor segmentation with Deep Neural Networks , 2015, Medical Image Anal..
[13] M. Gilbert,et al. Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study. , 2019, Radiology.
[14] Marion Smits,et al. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. , 2015, Neuro-oncology.
[15] M A Deeley,et al. Comparison of manual and automatic segmentation methods for brain structures in the presence of space-occupying lesions: a multi-expert study , 2011, Physics in medicine and biology.
[16] B. Rosen,et al. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation , 2013, Proceedings of the National Academy of Sciences.
[17] Mark W. Woolrich,et al. FSL , 2012, NeuroImage.
[18] D. Oldridge,et al. MRI features predict survival and molecular markers in diffuse lower-grade gliomas , 2017, Neuro-oncology.
[19] Konstantinos Kamnitsas,et al. Efficient multi‐scale 3D CNN with fully connected CRF for accurate brain lesion segmentation , 2016, Medical Image Anal..
[20] Stephen M. Moore,et al. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository , 2013, Journal of Digital Imaging.
[21] A. M. Dale,et al. A hybrid approach to the skull stripping problem in MRI , 2004, NeuroImage.
[22] Zoubin Ghahramani,et al. Dropout as a Bayesian Approximation: Representing Model Uncertainty in Deep Learning , 2015, ICML.
[23] Paul M. Thompson,et al. Robust Brain Extraction Across Datasets and Comparison With Publicly Available Methods , 2011, IEEE Transactions on Medical Imaging.
[24] Richard M. Leahy,et al. BrainSuite: An Automated Cortical Surface Identification Tool , 2000, MICCAI.
[25] Lawrence H. Schwartz,et al. Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab , 2017, Neuro-oncology.
[26] M. J. van den Bent,et al. Imaging Correlates of Adult Glioma Genotypes. , 2017, Radiology.
[27] Bruce R. Rosen,et al. DeepNeuro: an open-source deep learning toolbox for neuroimaging , 2018, Neuroinformatics.
[28] Bradley J. Erickson,et al. Automated Segmentation of Hyperintense Regions in FLAIR MRI Using Deep Learning , 2016, Tomography.
[29] Ninon Burgos,et al. New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .
[30] Alexander R. Pico,et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. , 2015, The New England journal of medicine.
[31] Klaus H. Maier-Hein,et al. Deep MRI brain extraction: A 3D convolutional neural network for skull stripping , 2016, NeuroImage.
[32] R W Cox,et al. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. , 1996, Computers and biomedical research, an international journal.